Antibodies elicited by a virosomally formulated Plasmodium falciparum serine repeat antigen-5 derived peptide detect the processed 47 kDa fragment both in sporozoites and merozoites

Peptides

Volumn 28, Issue 10, 2007, Pages 2051-2060

  Okitsu, Shinji L ^a   Boato, Francesca ^c   Mueller, Markus S ^a   Li, Dong Bo ^c   Vogel, Denise ^a   Westerfeld, Nicole ^b   Zurbriggen, Rinaldo ^b   Robinson, John A ^c   Pluschke, Gerd ^a  

^a SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^b Pevion Biotech Ltd   (Switzerland)

^c UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Malaria vaccine; Serine repeat antigen 5; Synthetic peptides; Virosomes

Indexed keywords

INFLUENZA VACCINE; MALARIA VACCINE; PEPTIDE ANTIBODY; PHOSPHATIDYLETHANOLAMINE; SERINE; SERINE REPEAT ANTIGEN 5; UNCLASSIFIED DRUG; VIROSOME;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CROSS REACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HOST CELL; HOST PARASITE INTERACTION; IMMUNOFLUORESCENCE; IMMUNOGENICITY; MEROZOITE; MOUSE; MYELOMA CELL; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROTEIN PROCESSING; SPOROZOITE; WESTERN BLOTTING;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; BLOTTING, WESTERN; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME-LINKED IMMUNOSORBENT ASSAY; MALARIA VACCINES; MEROZOITES; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; PLASMODIUM FALCIPARUM; SPOROZOITES;

MUS; PLASMODIUM FALCIPARUM;

EID: 34548672358     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2007.08.007     Document Type: Article

References (43)

1. Aoki S., Li J., Itagaki S., Okech B.A., Egwang T.G., Matsuoka H., et al. Serine repeat antigen (SERA5) is predominantly expressed among the SERA multigene family of Plasmodium falciparum, and the acquired antibody titers correlate with serum inhibition of the parasite growth. J Biol Chem 277 (2002) 47533
2. Bouharoun-Tayoun H., Attanath P., Sabchareon A., Chongsuphajaisiddhi T., and Druilhe P. Antibodies that protect humans against Plasmodium falciparum blood stages do not on their own inhibit parasite growth and invasion in vitro, but act in cooperation with monocytes. J Exp Med 172 (1990) 1633-1641
3. Bouharoun-Tayoun H., Oeuvray C., Lunel F., and Druilhe P. Mechanisms underlying the monocyte-mediated antibody-dependent killing of Plasmodium falciparum asexual blood stages. J Exp Med 182 (1995) 409
4. Chulay J.D., Lyon J.A., Haynes J.D., Meierovics A.I., Atkinson C.T., and Aikawa M. Monoclonal antibody characterization of Plasmodium falciparum antigens in immune complexes formed when schizonts rupture in the presence of immune serum. J Immunol 139 (1987) 2768-2774
5. Debrabant A., and Delplace P. Leupeptin alters the proteolytic processing of P126, the major parasitophorous vacuole antigen of Plasmodium falciparum. Mol Biochem Parasitol 33 (1989) 151-158
6. Debrabant A., Maes P., Delplace P., Dubremetz J.F., Tartar A., and Camus D. Intramolecular mapping of Plasmodium falciparum P126 proteolytic fragments by N-terminal amino acid sequencing. Mol Biochem Parasitol 53 (1992) 89-95
7. Delplace P., Bhatia A., Cagnard M., Camus D., Colombet G., Debrabant A., et al. Protein p126: a parasitophorous vacuole antigen associated with the release of Plasmodium falciparum merozoites. Biol Cell 64 (1988) 215-221
8. Delplace P., Dubremetz J.F., Fortier B., and Vernes A. A 50 kilodalton exoantigen specific to the merozoite release-reinvasion stage of Plasmodium falciparum. Mol Biochem Parasitol 17 (1985) 239-251
9. Delplace P., Fortier B., Tronchin G., Dubremetz J.F., and Vernes A. Localization, biosynthesis, processing and isolation of a major 126 kDa antigen of the parasitophorous vacuole of Plasmodium falciparum. Mol Biochem Parasitol 23 (1987) 193-201
10. Dorn A., Stoffel R., Matile H., Bubendorf A., and Ridley R.G. Malarial haemozoin/beta-haematin supports haem polymerization in the absence of protein. Nature 374 (1995) 269-271
11. Enders B., Hundt E., and Knapp B. Protection of Aotus monkeys after immunization with recombinant antigens of Plasmodium falciparum. Mem Inst Oswaldo Cruz 87 Suppl. 3 (1992) 413-422
12. Fox B.A., and Bzik D.J. Analysis of stage-specific transcripts of the Plasmodium falciparum serine repeat antigen (SERA) gene and transcription from the SERA locus. Mol Biochem Parasitol 68 (1994) 133-144
13. Fox B.A., Horii T., and Bzik D.J. Plasmodium falciparum: fine-mapping of an epitope of the serine repeat antigen that is a target of parasite-inhibitory antibodies. Exp Parasitol 101 (2002) 69
14. Fox B.A., Xing-Li P., Suzue K., Horii T., and Bzik D.J. Plasmodium falciparum: an epitope within a highly conserved region of the 47-kDa amino-terminal domain of the serine repeat antigen is a target of parasite-inhibitory antibodies. Exp Parasitol 85 (1997) 121
15. Gardner M.J., Shallom S.J., Carlton J.M., Salzberg S.L., Nene V., Shoaibi A., et al. Sequence of Plasmodium falciparum chromosomes 2, 10, 11 and 14. Nature 419 (2002) 531-534
16. Greenwood B. Malaria vaccines. Evaluation and implementation. Acta Trop 95 (2005) 298-304
17. Hall N., Pain A., Berriman M., Churcher C., Harris B., Harris D., et al. Sequence of Plasmodium falciparum chromosomes 1, 3-9 and 13. Nature 419 (2002) 527-531
18. Hodder A.N., Drew D.R., Epa V.C., Delorenzi M., Bourgon R., Miller S.K., et al. Enzymic, phylogenetic, and structural characterization of the unusual papain-like protease domain of Plasmodium falciparum SERA5. J Biol Chem 278 (2003) 48169
19. Inselburg J., Bathurst I.C., Kansopon J., Barchfeld G.L., Barr P.J., and Rossan R.N. Protective immunity induced in Aotus monkeys by a recombinant SERA protein of Plasmodium falciparum: adjuvant effects on induction of protective immunity. Infect Immunol 61 (1993) 2041-2047
20. Inselburg J., Bzik D.J., Li W.B., Green K.M., Kansopon J., Hahm B.K., et al. Protective immunity induced in Aotus monkeys by recombinant SERA proteins of Plasmodium falciparum. Infect Immunol 59 (1991) 1247-1250
21. Jafarshad A., Dziegiel M.H., Lundquist R., Nielsen L.K., Singh S., and Druilhe P.L. A novel antibody-dependent cellular cytotoxicity mechanism involved in defense against malaria requires costimulation of monocytes Fc{gamma}RII and Fc{gamma}RIII. J Immunol 178 (2007) 3099-3106
22. James S., Moehle K., Renard A., Mueller M.S., Vogel D., Zurbriggen R., et al. Synthesis, solution structure and immune recognition of an epidermal growth factor-like domain from Plasmodiun falciparum merozoite surface protein-1. Chem Biochem 14 (2007) 577-588
23. Knapp B., Hundt E., Nau U., and Kupper H.A. Molecular cloning, genomic structure and localization in a blood stage antigen of Plasmodium falciparum characterized by a serine stretch. Mol Biochem Parasitol 32 (1989) 73-83
24. Lambros C., and Vanderberg J.P. Synchronization of Plasmodium falciparum erythrocytic stages in culture. J Parasitol 65 (1979) 418-420
25. Le Roch K.G., Zhou Y., Blair P.L., Grainger M., Moch J.K., Haynes J.D., et al. Discovery of gene function by expression profiling of the malaria parasite life cycle. Science 301 (2003) 1503-1508
26. Li J., Mitamura T., Fox B.A., Bzik D.J., and Horii T. Differential localization of processed fragments of Plasmodium falciparum serine repeat antigen and further processing of its N-terminal 47 kDa fragment. Parasitol Int 51 (2002) 343
27. Liu Q., Ferreira M.U., Ndawi B.T., Ohmae H., Adagu I.S., Morikawa T., et al. Sequence diversity of serine repeat antigen gene exon II of Plasmodium falciparum in worldwide collected wild isolates. Southeast Asian J Trop Med Public Health 31 (2000) 808-817
28. Matile H., and Pink R. Plasmodium falciparum malaria parasite cultures and their use in immunology. In: Lefkovits I., and Pernis B. (Eds). Immunological Methods, vol. IV (1990), Academic Press, San Diego, CA p. 221
29. Moorthy V.S., and Dubovsky F. Progress in development of a vaccine to aid malaria control (2005), ASM Press, Washington, DC
30. Moreno R., Jiang L., Moehle K., Zurbriggen R., Gluck R., Robinson J.A., et al. Exploiting conformationally constrained peptidomimetics and an efficient human-compatible delivery system in synthetic vaccine design. Chem Biochem 2 (2001) 838
31. Morimatsu K., Morikawa T., Tanabe K., Bzik D.J., and Horii T. Sequence diversity in the amino-terminal 47 kDa fragment of the Plasmodium falciparum serine repeat antigen. Mol Biochem Parasitol 86 (1997) 249-254
32. Mueller M.S., Renard A., Boato F., Vogel D., Naegeli M., Zurbriggen R., et al. Induction of parasite growth-inhibitory antibodies by a virosomal formulation of a peptidomimetic of loop I from domain III of Plasmodium falciparum apical membrane antigen 1. Infect Immunol 71 (2003) 4749
33. Okech B., Mujuzi G., Ogwal A., Shirai H., Horii T., and Egwang T.G. High titers of IgG antibodies against Plasmodium falciparum serine repeat antigen 5 (SERA5) are associated with protection against severe malaria in Ugandan children. Am J Trop Med Hyg 74 (2006) 191-197
34. Okitsu S.L., Kienzl U., Moehle K., Silvie O., Peduzzi E., Mueller M.S., et al. Structure-activity-based design of a synthetic malaria peptide eliciting sporozoite inhibitory antibodies in a virosomal formulation. Chem Biol 14 (2007) 577-587
35. Perkins M.E., and Ziefer A. Preferential binding of Plasmodium falciparum SERA and rhoptry proteins to erythrocyte membrane inner leaflet phospholipids. Infect Immunol 62 (1994) 1207
36. Pfeiffer B., Peduzzi E., Moehle K., Zurbriggen R., Gluck R., Pluschke G., et al. A virosome-mimotope approach to synthetic vaccine design and optimization: synthesis, conformation, and immune recognition of a potential malaria-vaccine candidate. Angew Chem Int Ed Engl 42 (2003) 2368
37. Poltl-Frank F., Zurbriggen R., Helg A., Stuart F., Robinson J., Gluck R., et al. Use of reconstituted influenza virus virosomes as an immunopotentiating delivery system for a peptide-based vaccine. Clin Exp Immunol 117 (1999) 496
38. Safitri I., Jalloh A., Tantular I.S., Pusarawati S., Win T.T., Liu Q., et al. Sequence diversity in the amino-terminal region of the malaria-vaccine candidate serine repeat antigen in natural Plasmodium falciparum populations. Parasitol Int 52 (2003) 117
39. Soe S., Singh S., Camus D., Horii T., and Druilhe P. Plasmodium falciparum serine repeat protein, a new target of monocyte-dependent antibody-mediated parasite killing. Infect Immunol 70 (2002) 7182
40. Stuber D., Bannwarth W., Pink J.R., Meloen R.H., and Matile H. New B cell epitopes in the Plasmodium falciparum malaria circumsporozoite protein. Eur J Immunol 20 (1990) 819
41. Targett G.A. Malaria vaccines 1985-2005: a full circle?. Trends Parasitol 21 (2005) 499-503
42. Trang D., Huy N., Kariu T., Tajima K., and Kamei K. One-step concentration of malarial parasite-infected red blood cells and removal of contaminating white blood cells. Malaria J 3 (2004) 7
43. Zurbriggen R. Immunostimulating reconstituted influenza virosomes. Vaccine 21 (2003) 921